ZYXEL
27.2.2024 16:55:34 CET | Business Wire | Press release
Türk Telekom, pioneer of digital transformation Türkiye, has completed the world’s first mass deployment of Software-Defined Fiber Broadband. By using Netsia’s BB Suite and Zyxel’s Whitebox OLT, Türk Telekom has taken an important step towards fulfilling its virtualized and disaggregated broadband network strategy and thus, providing world-class, modern, high quality and high-speed broadband services.
“Beyond our role as a telecommunications operator, we are leading Türkiye's ambition to become a significant player in technology exports through our pioneering initiatives and partnerships. While supporting our local ecosystem through collaborations within our country, we are also elevating the prestige and value of our nation through our global endeavors," says Ümit Önal, CEO at Türk Telekom. “The cutting-edge fiber infrastructure technology product Zyxel, developed by Argela, our company renowned for innovative solutions, along with its US subsidiary Netsia, has evolved into an innovation that sets global standards. We are delighted to contribute to our country's vision of becoming a technology-exporting nation through the contract we have signed with Zyxel.”
Zyxel and Netsia have successfully completed the integration of Zyxel’s SDA Series Combo Whitebox OLT with Netsia’s BB Suite to realize the fully disaggregated broadband access network. The integrated solution has been tested in Türk Telekom’s live network and is now ready for deployment by all service providers globally. The partnership was made official with a contract signing ceremony held at this year’s Mobile World Congress on February 27. In attendance for the signing ceremony was Republic of Türkiye Deputy Transport and Infrastructure Minister Ömer Fatih Sayan.
The Netsia BB Suite provides network operators with an open, multi-vendor platform based on open-source SEBA project and BBF data models. Netsia BB Suite enables network operators to extend software defined programming to the fixed access network with customized support for each operator’s unique services and workflows. By enabling a fully disaggregated network, service providers are no longer committed to one vendor to fulfill all their needs. Instead, they have full flexibility to choose products and partners that work best for them, while having the flexibility to customize the solution to their needs.
Türk Telekom chose Zyxel’s Multi SDA products , which are all-in-one PON Whitebox OLT’s that are fully equipped to provide scalability, flexibility and interoperability to the Netsia BB Suite. The OLT’s have features that simultaneously support XGS-PON, GPON and Combo PON technologies, designed to make it easier for operators to adopt new technologies that integrate seamlessly with this solution.
“Netsia’s BB Suite is one of the most mature versatile solutions in the market, and our SDA Series Combo is designed to jointly further the network disaggregation evolution,” says Karsten Gewecke, President at Zyxel Communications. “We wanted to develop a flexible, future proof solution that creates an open broadband-access environment with vendor-agnostic hardware, keeping service providers ahead of the competition.”
Netsia CEO C. Bora Eliaçık says: “Türk Telekom, a globally recognized leader in telecommunications, is at the forefront of innovation in the Software-defined Fiber Broadband arena. We are honored to partner with them on this transformative journey. Our Netsia BB Suite product is designed to revolutionize how operators manage their access networks by providing a unified, powerful management solution. This collaboration marks a significant milestone in the evolution of access network management.” Eliaçık adds: “Our BB Suite allows the broadband access network to adapt itself to different service requirements and customer experience needs. The solution also supports the operators to optimize the CAPEX and OPEX costs by breaking the vendor lock, allowing more controllable and flexible PON networks and thus enabling critical features and services in the network. Our cooperation with Zyxel is extremely fruitful and we thank them for their collaboration and look forward to continuing our successful partnership.”
About Türk Telekom:
Türk Telekom, with over 180 years of history, is the first integrated telecommunications operator in Türkiye. Having a wide service network and product range in the fields of individual and corporate services, Türk Telekom unified its mobile, internet, phone and TV products and services under the single “Türk Telekom” brand. “Türkiye’s Multiplay Provider” Türk Telekom has 17.4 million fixed access lines, 15.1 million fixed broadband, 26.1 million mobile and 2.9 million TV subscribers as of September 30, 2023. Türk Telekom Group Companies provide services in all 81 cities of Türkiye with nearly 38.000 employees with the vision of introducing new technologies to Türkiye and accelerating Türkiye’s transformation into an information society. www.turktelekom.com.tr
About Netsia:
Netsia, a US subsidiary of Argela, is based in Santa Clara, California in the heart of Silicon Valley. With key architects, engineers and product people, Netsia is developing leading edge solutions for the telecom industry. Netsia is in active participation with open source communities and standards bodies and provides enriched, telco-grade, and supported distributions of the open source platforms. www.netsia.com
About Zyxel Communications
Zyxel Communications delivers technological innovations and has connected the world to the internet for more than 30 years. Whether establishing access through fixed or mobile broadband solutions, Zyxel Communications offers a comprehensive and flexible portfolio of products that’s keeping service providers ahead of the competition. Come by our booth at MWC 2024 to know more about our solutions and partnerships: Homepage | EMEA | Zyxel
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240227158748/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom